Katherine V Stultz - 13 Jan 2021 Form 4 Insider Report for Graphite Bio, Inc. (LENZ)

Reporting relationship: CHIEF OPERATING OFFICER
Issuer ticker: LENZ
Reported as of: 13 Jan 2021
Net transaction value: +$100,001
SEC form: 4
Accepted by SEC: 01 Jul 2021, 19:01:02 UTC
Next SEC filing: 24 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Franco Valle, attorney-in-fact

Key filing fact

Katherine V Stultz filed Form 4 for Graphite Bio, Inc. (LENZ) on 01 Jul 2021.

Key facts

This page summarizes Katherine V Stultz's Form 4 filing for Graphite Bio, Inc. (LENZ).
6 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 01 Jul 2021, 19:01.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$100,001.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GRPH transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +8,126
Change %: +3.9%
Price
Shares after: 216,020
Date: 29 Jun 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GRPH transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +99,753
Change %
Price: $0.000000
Shares after: 99,753
Date: 13 Jan 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 99,753
Exercise price: $0.3000
Footnotes: F2, F3, F4

GRPH transaction Derivative

Series B Preferred Stock

Award

Transaction value: $100,001
Shares: +19,763
Change %
Price: $5.06
Shares after: 19,763
Date: 11 Mar 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,126
Exercise price
Footnotes: F1, F3

GRPH transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +209,846
Change %
Price: $0.000000
Shares after: 209,846
Date: 17 Mar 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 209,846
Exercise price: $6.11
Footnotes: F2, F3, F5

GRPH transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +89,934
Change %
Price: $0.000000
Shares after: 89,934
Date: 17 Mar 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 89,934
Exercise price: $6.11
Footnotes: F2, F6

GRPH transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -19,763
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,126
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.

Footnote F2

On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split.

Footnote F3

This transaction occurred prior to the IPO and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

Footnote F4

25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after August 31, 2020, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase.

Footnote F5

1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.

Footnote F6

The option was granted subject to the achievement by the Company of performance vesting criteria. On June 29, 2021 the performance vesting criteria was met such that the option became reportable. 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.